ArticleDermatology and therapy2025

Effectiveness of Tildrakizumab 200 mg in Moderate-to-Severe Plaque Psoriasis: A Multicenter Real-World Study Analyzing Patient Outcomes by Weight, PASI, BMI, and Previous Therapies.

Emanuele Trovato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.